 |
|
|
|
 |
 |
Investigator |
|
Institution |
|
Project |
|
|
Krys Bankiewicz, MD PhD |
|
University of California
San Francisco |
|
Convection-Enhanced Delivery of
Immunoliposomes in Pre-clinical Models |
|
|
Keith Black, MD |
|
Cedars Sinai |
|
Modulation of Blood-Brain Tumor
Barrier Permeability in Glioblastoma Multiforme Xenograft Model &
Patients with Brain Metastases |
|
|
E. Antonio Chiocca, MD PhD |
|
Harvard Medical School,
Massachusetts General Hospital |
|
Preclinical Efficacy Toxicity
Evaluation of an Intra-arterial Oncolytic Virus & Transient
Immunosuppression |
|
|
Alex Franzusoff, PhD |
|
University of Colorado |
|
The Development of Novel Brain Tumor
Vaccines |
|
|
Matthias
Gromeier, MD |
|
Duke University |
|
Non-Pathogenic Poliovirus
Recombinants for the Treatment of Malignant Glioma |
|
|
Paul
Mischel, MD |
|
University of California
Los Angeles |
|
Development of a Targeted Therapy
for Glioblastoma Multiforme |
|
|
Jeffrey Rothstein, MD PhD |
|
Johns Hopkins University |
|
Anti-Excitotoxic Therapies to Target
Glioma Growth |
|
|
John Sampson, MD PhD |
|
Duke University |
|
Modeling & Perfecting
Convection-Enhanced Delivery of an EGFR-specific Immunotoxin for the
Treatment of Malignant Brain Tumors |
|
|
Jann Sarkaria, MD |
|
Mayo Clinic |
|
Identification of Predictive Markers
for Response to Combined Radiation/EGFR Inhibitor Therapy in Malignant
Gliomas |
|
|
Charles Sawyers, MD |
|
University of California
Los Angeles |
|
Microarray Analysis of Glioblastoma:
Defining a Fingerprint of PTEN Loss for Application to Clinical Trials |
|
 |
|
|
|
 |
